Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates
暂无分享,去创建一个
D. Montefiori | R. Sanders | M. V. van Gils | J. Torres | G. Ozorowski | H. Gao | A. Antanasijevic | H. Gao | G. Scarlatti | Y. Aldon | M. Claireaux | M. M. van Haaren | J. Burger | I. Bontjer | R. Le Grand | M. Kaduk | P. Mundsperger | M. Tolazzi | N. Dereuddre-Bosquet | M. Crispin | P. Maisonnasse | A. Ward | Wen‐Hsin Lee | J. Allen | J. van Schooten | A. Aartse | H. Chawla | R. Shattock | G. K. Karlsson Hedestam | N. Vázquez Bernat | E. Reiss
[1] Q. Sattentau,et al. High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers , 2022, npj Vaccines.
[2] M. Corcoran,et al. VDJ Gene Usage in IgM Repertoires of Rhesus and Cynomolgus Macaques , 2022, Frontiers in Immunology.
[3] P. C. Seth,et al. A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target , 2021, Viruses.
[4] John P. Moore,et al. Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates , 2021, PLoS pathogens.
[5] J. Moore,et al. Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein , 2021, Journal of virology.
[6] J. Mascola,et al. Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization , 2021, bioRxiv.
[7] Allan C. deCamp,et al. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. , 2021, The New England journal of medicine.
[8] B. Murrell,et al. Rhesus and cynomolgus macaque immunoglobulin heavy-chain genotyping yields comprehensive databases of germline VDJ alleles , 2021, Immunity.
[9] John P. Moore,et al. Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike , 2020, bioRxiv.
[10] S. Christley,et al. Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates , 2020, bioRxiv.
[11] D. Baker,et al. Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens , 2020, bioRxiv.
[12] Daniel W. Kulp,et al. Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance , 2018, Cell.
[13] J. Mascola,et al. Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability , 2019, Immunity.
[14] D. Baker,et al. Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle , 2019, Nature Communications.
[15] John P. Moore,et al. Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence , 2019, Nature Communications.
[16] B. Haynes,et al. Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting , 2019, PloS one.
[17] P. Ghys,et al. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. , 2019, The Lancet. Infectious diseases.
[18] Daniel W. Kulp,et al. Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers , 2019, Immunity.
[19] Erik Lindahl,et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.
[20] D. Burton,et al. Recent progress in broadly neutralizing antibodies to HIV , 2018, Nature Immunology.
[21] L. McCoy. The expanding array of HIV broadly neutralizing antibodies , 2018, Retrovirology.
[22] Bette Korber,et al. Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth , 2018, Cell reports.
[23] A. Ward,et al. Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers , 2018, Cell reports.
[24] D. Burton,et al. Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization , 2018, Immunity.
[25] J. Mascola,et al. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1 , 2018, Nature Medicine.
[26] B. Pulendran,et al. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques , 2018, PLoS pathogens.
[27] John P. Moore,et al. Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination , 2018, Journal of Virology.
[28] L. Stamatatos,et al. Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo , 2017, The Journal of experimental medicine.
[29] Richard T. Wyatt,et al. Particulate Array of Well‐Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach , 2017, Immunity.
[30] D. Burton,et al. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure , 2017, Immunity.
[31] S. Crotty,et al. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem , 2017, Immunological reviews.
[32] G. B. Karlsson Hedestam,et al. Production of individualized V gene databases reveals high levels of immunoglobulin genetic diversity , 2016, Nature Communications.
[33] John P. Moore,et al. An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability , 2016, Nature Microbiology.
[34] Bryan Briney,et al. Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies. , 2016, Cell reports.
[35] John P. Moore,et al. Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes , 2015, Cell.
[36] J. Mascola,et al. Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques , 2014, The Journal of experimental medicine.
[37] Hongmei Gao,et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. , 2014, Journal of immunological methods.
[38] S. Zolla-Pazner,et al. Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques , 2013, Mucosal Immunology.
[39] Raphael Gottardo,et al. Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2013, Journal of Virology.
[40] Xuesong Yu,et al. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells. , 2012, Journal of immunological methods.
[41] Q. Sattentau,et al. International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II , 2009, PloS one.
[42] Young Do Kwon,et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 , 2011, Nature.
[43] P. Sharp,et al. Origins of HIV and the AIDS pandemic. , 2011, Cold Spring Harbor perspectives in medicine.
[44] J. Mascola,et al. Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 , 2010, Journal of Virology.
[45] Thomas D. Goddard,et al. Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions. , 2010, Journal of structural biology.
[46] Christopher Irving,et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. , 2009, Journal of structural biology.
[47] S Gnanakaran,et al. Appreciating HIV type 1 diversity: subtype differences in Env. , 2009, AIDS research and human retroviruses.
[48] David C Montefiori,et al. Measuring HIV neutralization in a luciferase reporter gene assay. , 2009, Methods in molecular biology.
[49] S. Hammer,et al. The challenge of HIV-1 subtype diversity. , 2008, The New England journal of medicine.
[50] Feng Gao,et al. A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. , 2006, Virology.
[51] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[52] Anchi Cheng,et al. Automated molecular microscopy: the new Leginon system. , 2005, Journal of structural biology.
[53] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..